Gürlevik, E., & Longerich, T. (2013). Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma. Hepatology, 58(3), . https://doi.org/https://doi.org/10.1002/hep.26468
Chicago Style (17th ed.) CitationGürlevik, Engin, and Thomas Longerich. "Adjuvant Gemcitabine Therapy Improves Survival in a Locally Induced, R0-resectable Model of Metastatic Intrahepatic Cholangiocarcinoma." Hepatology 58, no. 3 (2013). https://doi.org/https://doi.org/10.1002/hep.26468.
MLA (9th ed.) CitationGürlevik, Engin, and Thomas Longerich. "Adjuvant Gemcitabine Therapy Improves Survival in a Locally Induced, R0-resectable Model of Metastatic Intrahepatic Cholangiocarcinoma." Hepatology, vol. 58, no. 3, 2013, https://doi.org/https://doi.org/10.1002/hep.26468.